CAS: 1372540-25-4 - GSK2636771
Ref: AN-AG009CC3
| 1mg | 54,00 € | |
| 5mg | 93,00 € | |
| 10mg | 113,00 € | |
| 50mg | 225,00 € |
Entrega estimada em Estados Unidos, Terça-feira 28 de Maio de 2024
GSK2636771
CAS:1372540-25-4
GSK2636771, an effective, specific, orally bioavailable, PI3Kβ inhibitor, has been used in cancer, lymphoma, solid …
Fórmula:
C22H22F3N3O3
Pureza:
99.74%
Cor e Forma:
Solid
Peso molecular:
433.42
Ref: TM-T2073
| 1mg | 42,00 € | |
| 2mg | 56,00 € | |
| 5mg | 87,00 € | |
| 10mg | 147,00 € | |
| 25mg | 248,00 € | |
| 50mg | 353,00 € | |
| 100mg | 535,00 € | |
| 1ml*10 (DMSO) | 88,00 € |
Entrega estimada em Estados Unidos, Segunda-feira 3 de Junho de 2024
Ref: TR-G797495
| 2500µg | 195,00 € |
Entrega estimada em Estados Unidos, Sexta-feira 5 de Julho de 2024
![2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid](https://static.cymitquimica.com/products/3D/thumb/FM102909.jpg)
2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid
CAS:1372540-25-4
2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid (BIC) is a strain that is categorized as a cancer drug. It has …
Fórmula:
C22H22F3N3O3
Pureza:
Min. 95%
Peso molecular:
433.42 g/mol
Ref: 3D-FM102909
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar |
Entrega estimada em Estados Unidos, Segunda-feira 8 de Julho de 2024
